The third day of admission resulted in serology studies, with thyroid-stimulating immunoglobulin of 127 IU/L, thyroglobulin antibody < 1.0 IU/mL, thyroid peroxidase antibody of 281 IU/mLco, and thyroid-stimulating hormone receptor antibody of 39.60 IU/L, indicating Grave’s disease. This evidence concerns the gene TSHR and Graves disease.